Skip to main content

Ophthalmic Community Emphasizes Cost Measure Issues With CMS

The Academy and other groups participated in an Oct. 4 meeting with CMS in which we successfully convinced the agency that the diabetes cost measure is not applicable to ophthalmology. Members who believe they have been incorrectly applied cost measures have until 8 p.m. ET Monday, Oct. 9, to submit a targeted review.

After repeated entreaties urging the Centers for Medicare & Medicaid Services (CMS) to correct issues in its Merit-Based Incentive Payment System (MIPS) diabetes cost measure methodology, the Academy and others from the ophthalmic community successfully clarified our concerns with the Center for Clinical Standards and Quality team and its measure development contractor, Acumen.

We were able to help CMS understand that ophthalmologists typically practice in a single specialty group and are not responsible for managing diabetes care.

CMS committed to fixing the group attribution in its calculation of 2023 cost measure performance and plans to improve transparency by sharing details on the revised measure publicly. While the agency did not commit to fixing the problem in 2022 performance scores, it assured us it would discuss its options internally.

The Academy has heard from members that in their final score preview for the 2022 MIPS performance year, CMS has incorrectly applied the cost measure for managing patients with diabetes to some ophthalmologists who participate in MIPS as a group.

Working with the American Society of Retina Specialists (ASRS) and American Society of Cataract and Refractive Surgery (ASCRS), we raised the issue in a joint letter on Jun. 28.

Our meeting Wednesday was a culmination of efforts to engage CMS and we were pleased that Michelle Schreiber, MD, deputy director for Quality & Value, attended the meeting. While CMS is considering how to address 2022 scores, Dr. Schreiber encourages ophthalmologists being scored on the diabetes cost measure to file a targeted review. CMS plans to take another look at the targeted reviews that have been submitted related to this particular cost measure, including the ones that have been denied.

The Academy continues to press CMS to also correct problems related to the cataract cost measure. CMS has alerted us that it has updated the patient level data files to remove duplicates, but we remain concerned about the effectiveness of this process, due to the lack of transparency from the agency regarding its efforts. We are in the process of scheduling a meeting with CMS to discuss these concerns.

Targeted Review

If you see these issues or believe another error has been made in your MIPS score, submit a request for a targeted review by 8 p.m. ET Monday, Oct. 9. The Academy has developed suggested language for you to use in your targeted review, depending which cost measure you believe has been incorrectly calculated for you or your group. Tailor these templates to your specific practice and situation.

Here is the draft language:

Diabetes Cost Measure

Cataract Cost Measure

Related Stories

Member exclusive - Locked
HHS

2027 Fee Schedule Finalizes Pay Cut to Physicians Between 1.8% and 2.3%

The final rule from the Centers for Medicare & Medicaid Services (CMS) includes a 2.31% payment cut for physicians not participating in qualifying APMs and a 1.83% pay cut for qualifying Alternative Payment Model (APM) participants. 

HHS

CMS Proposes New Medicare Advantage Provider Directory Requirements

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would implement the Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act, enacted as part of the Consolidated Appropriations Act, 2026.

Member exclusive - Locked
CMS page on 2025 MIPS performance scores

Review Your 2025 MIPS Final Score and 2027 Payment Adjustment, Request a Targeted Review if Needed

CMS has released 2025 Merit-Based Incentive Payment System (MIPS) performance scores and feedback. Reviewing and possibly requesting a targeted review of your score is important for determining your 2027 payment.

Latest Updates

Member exclusive - Locked
capital building side

OPHTHPAC Midterms Recap: What the Results Mean for Ophthalmology

The 2026 midterm results are nearly final, and thanks to the support of ophthalmologists nationwide, OPHTHPAC helped secure important victories for ophthalmology this election cycle: 100 of 114 OPHTHPAC-backed candidates won their general election races, with a few results still being finalized. Here is what this year’s results mean for ophthalmology.

Member exclusive - Locked
capital building side

Final Hospital Outpatient, ASC Rule: Pay Raises for Device-Intensive Procedures, But Cuts to Other Common Ophthalmic Surgeries

Hospital outpatient departments (HOPD) and ambulatory surgical centers will get a 2.3% payment increase in 2027. But the rule released Nov. 4 by the Centers for Medicare & Medicaid Services includes hidden reimbursement cuts for most ophthalmology surgeries.

Member exclusive - Locked
An exterior shot of the United States Capitol building

Academy Challenges Medicare Contractor on Vabysmo Denials and Audits Targeting Treat-and-Extend Dosing

Claim denials and audit failures has prompted the Academy to call on two Medicare administrative contractors to review polices on treat-and-extend dosing for the eye injection medication Vabysmo.